Discovering effective drug combinations may now be easier thanks to a screening platform made public today by St. Jude ...
Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.
Cancer researchers at the University of Tennessee Health Science Center have published three groundbreaking studies ...
New types of sensors can generate environmental data in real time using a range of tools, including flexible, printed ICs and ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed a novel artificial intelligence tool that not only ...
SMRTS, a smart mRNA system, enables cell‑selective gene expression, expanding the mRNA toolbox for precision cancer therapies.
FLAMeS, a new convolutional neural network, enhances MS lesion segmentation accuracy using only T2-weighted FLAIR images, ...
Mount Sinai scientists developed V2P, a powerful new AI tool that predicts how specific DNA mutations translate into disease, ...
News Medical on MSN
Novel AI tool not only identifies genetic mutations but also predicts the type of disease
Scientists at the Icahn School of Medicine at Mount Sinai have developed a novel artificial intelligence tool that not only identifies disease-causing genetic mutations but also predicts the type of ...
Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback